Author

T. Mazumder

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Satpathy· 1 shared B. Hwang· 1 shared B. Yu· 1 shared C. A. Tsuchida· 1 shared C. Chang· 1 shared C. H. June· 1 shared C. J. Ye· 1 shared C. R. Hopkins· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Satpathy

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells

C. A. Tsuchida, N. Brandes, R. Bueno, M. Trinidad, T. Mazumder, B. Yu, B. Hwang, C. Chang, J. Liu, Y. Sun, C. R. Hopkins, K. R. Parker, Y. Qi, A. Satpathy, E. Stadtmauer, , J. A. Doudna

This study investigates chromosome loss in CRISPR-Cas9-engineered T cells and shows a modified manufacturing process reduces it while preserving editing efficacy.

bioRxiv · Mar 22, 2023Cell Biology

In vitro and in vivo evidences propound therapeutic potential of Lipocalin 2 in cervical carcinoma

N. Dwivedi, T. Mazumder, G. Veeraraghavan, R. Siva, S. P K, R. Ranade, M. Das, S. K. Dhar

This study shows that inhibiting LCN2 with a monoclonal antibody reduces cervical cancer cell proliferation, invasion, and tumor growth in vitro and in vivo.

bioRxiv · Jan 13, 2023 · PreprintCancer Biology